Objective To observe the clinical and fibrinolytic effect of Urokinase (UK) therapy in the acute cerebral infarction, and alteration of D-dimer concentrations and plasmin activity.
目的观察尿激酶(UK)治疗急性脑梗死的疗效及血浆纤溶酶的活性变化。
We measured the plasminogen (PLG) content and plasmin (pl) activity in 54 leukemic patients.
对54例白血病患者进行血浆纤溶酶原(plg)及纤溶酶(PL)活性测定。
According to reports, Nattokinase has plasmin-like bio-characteristic that lyses fibrin directly, or increases activity of pro-urokinase and t-PA (Tissue Plasminogen Activator).
据报道，纳豆激酶有和胞浆素一样的可直接分解纤维蛋白的生物特性，或者增强尿激酶原和t—PA(人组织型纤溶酶原激活剂)的活性。
According to reports, Nattokinase has plasmin-like bio-characteristic that lyses fibrin directly, or increases activity of pro-urokinase and t-PA (Tissue Plasminogen Activator).
据报道，纳豆激酶有和胞浆素一样的可直接分解纤维蛋白的生物特性，或者增强尿激酶原和t—PA(人组织型纤溶酶原激活剂)的活性。
应用推荐